Viveon Health enters non-redemption agreement to extend business combination deadline to Sep 30, 2024

Viveon Health Acquisition Corp.

Non-redemption agreement with institutional investors: they agree not to redeem 550,000 public shares.
Special meeting to approve extension of business combination deadline from March 31, 2024 to September 30, 2024.
Sponsor forfeits 150,000 founder shares; company issues 150,000 new shares to investors for no additional consideration.
Investors may elect cash payment equal to 150,000 shares times final redemption price instead of new shares.
Securities now trade on OTC Pink after suspension from NYSE American; appeal pending.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Viveon Health Acquisition Corp. entered into Non-Redemption Agreement with Viveon Health LLC (the Sponsor) and certain institutional investors named therein (effective 2024-03-27).

Action: entry
Counterparty: Viveon Health LLC (the Sponsor) and certain institutional investors named therein
Effective: 2024-03-27

Exact text from the filing

On March 27, 2024, (the Company , entered into a non-redemption agreement (the “ Non-Redemption Agreement ”) with Viveon Health LLC (the “ Sponsor ”) and certain institutional investors named therein (the “ Investors ”).

View on SEC.gov

512 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0001493152-24-011386

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.